FEMASYS INC (FEMY)
US31447E1055 - Common Stock
Overall FEMY gets a fundamental rating of 2 out of 10. We evaluated FEMY against 195 industry peers in the Health Care Equipment & Supplies industry. FEMY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FEMY is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
FEMY had negative earnings in the past year.
In the past year FEMY has reported a negative cash flow from operations.
In the past 5 years FEMY always reported negative net income.
FEMY had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of FEMY (-51.33%) is worse than 67.69% of its industry peers.
Looking at the Return On Equity, with a value of -77.63%, FEMY is doing worse than 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -51.33% | ||
| ROE | -77.63% | ||
| ROIC | N/A |
ROA(3y)-48.37%
ROA(5y)-65%
ROE(3y)-60.33%
ROE(5y)-97.96%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 64.92%, FEMY is in the better half of the industry, outperforming 68.21% of the companies in the same industry.
In the last couple of years the Gross Margin of FEMY has declined.
FEMY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 64.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.76%
GM growth 5YN/A
2. Health
2.1 Basic Checks
FEMY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FEMY has more shares outstanding
Compared to 1 year ago, FEMY has a worse debt to assets ratio.
2.2 Solvency
FEMY has an Altman-Z score of -4.27. This is a bad value and indicates that FEMY is not financially healthy and even has some risk of bankruptcy.
FEMY's Altman-Z score of -4.27 is on the low side compared to the rest of the industry. FEMY is outperformed by 66.67% of its industry peers.
A Debt/Equity ratio of 0.34 indicates that FEMY is not too dependend on debt financing.
FEMY's Debt to Equity ratio of 0.34 is in line compared to the rest of the industry. FEMY outperforms 43.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.27 |
ROIC/WACCN/A
WACC9.44%
2.3 Liquidity
A Current Ratio of 7.59 indicates that FEMY has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 7.59, FEMY belongs to the top of the industry, outperforming 84.10% of the companies in the same industry.
FEMY has a Quick Ratio of 7.37. This indicates that FEMY is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of FEMY (7.37) is better than 87.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.59 | ||
| Quick Ratio | 7.37 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 4.17% over the past year.
FEMY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.04%.
The Revenue has been growing slightly by 1.01% on average over the past years.
EPS 1Y (TTM)4.17%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q24%
Revenue 1Y (TTM)-11.04%
Revenue growth 3Y1.01%
Revenue growth 5YN/A
Revenue growth Q2Q-7.34%
3.2 Future
Based on estimates for the next years, FEMY will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.00% on average per year.
Based on estimates for the next years, FEMY will show a very strong growth in Revenue. The Revenue will grow by 144.75% on average per year.
EPS Next Y13.15%
EPS Next 2Y22.97%
EPS Next 3Y18.58%
EPS Next 5Y15%
Revenue Next Year320.17%
Revenue Next 2Y254.27%
Revenue Next 3Y196.02%
Revenue Next 5Y144.75%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for FEMY. In the last year negative earnings were reported.
Also next year FEMY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as FEMY's earnings are expected to grow with 18.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.97%
EPS Next 3Y18.58%
5. Dividend
5.1 Amount
No dividends for FEMY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FEMASYS INC
NASDAQ:FEMY (4/26/2024, 7:00:00 PM)
After market: 1.3 +0.03 (+2.36%)1.27
-0.06 (-4.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap28.07M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -51.33% | ||
| ROE | -77.63% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 64.92% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 7.59 | ||
| Quick Ratio | 7.37 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)4.17%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y13.15%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.04%
Revenue growth 3Y1.01%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y